Cargando…

Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified

The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo. Sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Spielmans, Glen I., Spence-Sing, Tess, Parry, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031767/
https://www.ncbi.nlm.nih.gov/pubmed/32116839
http://dx.doi.org/10.3389/fpsyt.2020.00018
_version_ 1783499440546381824
author Spielmans, Glen I.
Spence-Sing, Tess
Parry, Peter
author_facet Spielmans, Glen I.
Spence-Sing, Tess
Parry, Peter
author_sort Spielmans, Glen I.
collection PubMed
description The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo. Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides. In this paper, we critically examine research regarding the Black Box warning’s alleged deleterious consequences. One study claimed that controlled trials did not actually find an increased risk of suicidality among youth taking fluoxetine relative to those taking placebo, but its measure of suicidality is likely invalid. We found that ecological time series studies claiming that decreasing antidepressant prescriptions are linked to higher rates of suicide attempts or actual suicides among youth were methodologically weak. These studies exhibited shortcomings including: selective use of time points, use of only a short-term time series, lack of performing statistical analysis, not examining level of severity/impairment among participants, inability to control confounding variables, and/or use of questionable measures of suicide attempts. Further, while some time-series studies claim that increased antidepressant prescriptions are related to fewer youth suicides, more recent data suggests that increasing antidepressant prescriptions are related to more youth suicide attempts and more completed suicides among American children and adolescents. We also note that case-control studies show increased risk of suicide attempts and suicide among youth taking antidepressants, even after controlling for some relevant confounds. As clinical trials have the greatest ability to control relevant confounds, it is important to remember such trials demonstrated increased risk of suicidality adverse events among youth taking antidepressants. The Black Box warning is firmly rooted in solid data whereas attempts to claim the warning has caused harm are based on quite weak evidence.
format Online
Article
Text
id pubmed-7031767
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70317672020-02-28 Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified Spielmans, Glen I. Spence-Sing, Tess Parry, Peter Front Psychiatry Psychiatry The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo. Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides. In this paper, we critically examine research regarding the Black Box warning’s alleged deleterious consequences. One study claimed that controlled trials did not actually find an increased risk of suicidality among youth taking fluoxetine relative to those taking placebo, but its measure of suicidality is likely invalid. We found that ecological time series studies claiming that decreasing antidepressant prescriptions are linked to higher rates of suicide attempts or actual suicides among youth were methodologically weak. These studies exhibited shortcomings including: selective use of time points, use of only a short-term time series, lack of performing statistical analysis, not examining level of severity/impairment among participants, inability to control confounding variables, and/or use of questionable measures of suicide attempts. Further, while some time-series studies claim that increased antidepressant prescriptions are related to fewer youth suicides, more recent data suggests that increasing antidepressant prescriptions are related to more youth suicide attempts and more completed suicides among American children and adolescents. We also note that case-control studies show increased risk of suicide attempts and suicide among youth taking antidepressants, even after controlling for some relevant confounds. As clinical trials have the greatest ability to control relevant confounds, it is important to remember such trials demonstrated increased risk of suicidality adverse events among youth taking antidepressants. The Black Box warning is firmly rooted in solid data whereas attempts to claim the warning has caused harm are based on quite weak evidence. Frontiers Media S.A. 2020-02-13 /pmc/articles/PMC7031767/ /pubmed/32116839 http://dx.doi.org/10.3389/fpsyt.2020.00018 Text en Copyright © 2020 Spielmans, Spence-Sing and Parry http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Spielmans, Glen I.
Spence-Sing, Tess
Parry, Peter
Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
title Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
title_full Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
title_fullStr Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
title_full_unstemmed Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
title_short Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
title_sort duty to warn: antidepressant black box suicidality warning is empirically justified
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031767/
https://www.ncbi.nlm.nih.gov/pubmed/32116839
http://dx.doi.org/10.3389/fpsyt.2020.00018
work_keys_str_mv AT spielmansgleni dutytowarnantidepressantblackboxsuicidalitywarningisempiricallyjustified
AT spencesingtess dutytowarnantidepressantblackboxsuicidalitywarningisempiricallyjustified
AT parrypeter dutytowarnantidepressantblackboxsuicidalitywarningisempiricallyjustified